Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China.
Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
Genomics Proteomics Bioinformatics. 2021 Oct;19(5):669-678. doi: 10.1016/j.gpb.2021.09.006. Epub 2021 Nov 5.
Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard to symptoms and mortality rates among populations. Humoral immunity plays critical roles in SARS-CoV-2 infection and recovery from COVID-19. However, differences in immune responses and clinical features among COVID-19 patients remain largely unknown. Here, we report a database for COVID-19-specific IgG/IgM immune responses and clinical parameters (named COVID-ONE-hi). COVID-ONE-hi is based on the data that contain the IgG/IgM responses to 24 full-length/truncated proteins corresponding to 20 of 28 known SARS-CoV-2 proteins and 199 spike protein peptides against 2360 serum samples collected from 783 COVID-19 patients. In addition, 96 clinical parameters for the 2360 serum samples and basic information for the 783 patients are integrated into the database. Furthermore, COVID-ONE-hi provides a dashboard for defining samples and a one-click analysis pipeline for a single group or paired groups. A set of samples of interest is easily defined by adjusting the scale bars of a variety of parameters. After the "START" button is clicked, one can readily obtain a comprehensive analysis report for further interpretation. COVID-ONE-hi is freely available at www.COVID-ONE.cn.
新型冠状病毒病(COVID-19)由 SARS-CoV-2 引起,其在不同人群中的症状和死亡率存在差异。体液免疫在 SARS-CoV-2 感染和 COVID-19 康复中起着关键作用。然而,COVID-19 患者的免疫反应和临床特征的差异在很大程度上仍不清楚。在这里,我们报告了一个 COVID-19 特异性 IgG/IgM 免疫反应和临床参数的数据库(命名为 COVID-ONE-hi)。COVID-ONE-hi 基于包含来自 783 例 COVID-19 患者的 2360 份血清样本的 IgG/IgM 反应数据,这些样本针对 28 个已知 SARS-CoV-2 蛋白中的 20 个和 2360 个血清样本中的 199 个刺突蛋白肽,这些蛋白对应 24 个全长/截断蛋白。此外,COVID-ONE-hi 将 2360 份血清样本的 96 个临床参数和 783 例患者的基本信息整合到数据库中。此外,COVID-ONE-hi 为定义样本提供了一个仪表板,并为单个组或配对组提供了一键式分析管道。通过调整各种参数的比例条,可以轻松定义一组感兴趣的样本。点击“开始”按钮后,即可轻松获得综合分析报告以供进一步解释。COVID-ONE-hi 可在 www.COVID-ONE.cn 上免费获取。